Moderna (MRNA) PT Raised to $95 at BofA Securities
Get Alerts MRNA Hot Sheet
Price: $110.59 --0%
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 8
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 8
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham raised the price target on Moderna (NASDAQ: MRNA) to $95.00 (from $70.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Downgrades NIBE Industrier AB (NIBEB:SW) (NDRBF) to Equalweight
- Hon Hai Precision Industry (2317:TT) (HNHPF) PT Raised to NT$170 at JPMorgan on increased NVDA orders
- Moderna secures $750 million from Blackstone Life Sciences to develop flu shots
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!